05/17/2022
Asrar Khan, MD; Derrick L. Green, MD, MBA; Steve Santilli, MD, PhD, MBA; Debra K. Johnson, RN; Selma Carlson, MD; Mackenzie Mbai, MD; Rosemary Kelly, MD; Amy A. Gravely, MS; Brad Bart, MD; Selcuk Adabag, MD, MS, FHRS; Santiago Garcia, MD; Qun Chen, PhD; Ion S. Jovin, MD; Edward Lesnefsky, MD; Edward McFalls, MD
C-reactive protein levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a short-term period of administration in patients undergoing elective vascular...
C-reactive protein levels may be reduced with long-term administration of ubiquinone (CoQ10) in patients with chronic ischemic heart disease, but the impact of a short-term period of administration in patients undergoing elective vascular...
C-reactive protein levels may be...
